Skip to main content
Actinium Pharmaceuticals, Inc. (ATNM)
NYSEAMERICAN: ATNM · Real-Time Price · USD
1.950
+0.070 (3.72%)
Sep 11, 2024, 4:00 PM EDT - Market closed

Actinium Pharmaceuticals Revenue

Actinium Pharmaceuticals had revenue of $81.00K in the twelve months ending June 30, 2024, up 80.00% year-over-year. In the year 2023, Actinium Pharmaceuticals had annual revenue of $81.00K, down -92.14%.

Revenue (ttm)
$81.00K
Revenue Growth
+80.00%
P/S Ratio
n/a
Revenue / Employee
$1,653
Employees
49
Market Cap
60.75M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202381.00K-949.00K-92.14%
Dec 31, 20221.03M-114.00K-9.97%
Dec 31, 20211.14M--
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Theratechnologies 82.57M
HOOKIPA Pharma 52.16M
Champions Oncology 50.16M
LENSAR 45.12M
Prenetics Global 23.23M
Kronos Bio 8.41M
Lexaria Bioscience 411.02K
Revenue Rankings

ATNM News

More News